Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study

Hepatitis C ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Curative Therapy

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

10.1016/j.jhep.2004.11.025 ◽

2005 ◽

Vol 42 (3) ◽

pp. 315-322 ◽

Cited By ~ 171

Author(s):

Nizar N. Zein ◽

for the Etanercept Study Group

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Study ◽

Phase 2 ◽

Hepatitis C Virus Infection ◽

Double Blind ◽

Double Blind Placebo ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve

P-347 A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1

Annals of Oncology ◽

10.1016/j.annonc.2020.04.429 ◽

2020 ◽

Vol 31 ◽

pp. S202-S203 ◽

Cited By ~ 2

Author(s):

B. Sangro ◽

M. Kudo ◽

S. Qin ◽

Z. Ren ◽

S. Chan ◽

...

Keyword(s):

Transarterial Chemoembolization ◽

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HEPATITIS C GENOTYPE 1: FINAL REPORT

10.1016/s0168-8278(10)61189-0 ◽

2010 ◽

Vol 52 ◽

pp. S461 ◽

Cited By ~ 3

Author(s):

M.L. Shiffman ◽

A. Ahmed ◽

I.M. Jacobson ◽

R.E. Pruitt ◽

E.B. Keeffe

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Final Report ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Peginterferon Alfa

Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study

Gut ◽

10.1136/gut.2007.131607 ◽

2007 ◽

Vol 57 (4) ◽

pp. 531-536 ◽

Cited By ~ 74

Author(s):

M R Kraus ◽

A Schafer ◽

K Schottker ◽

C Keicher ◽

B Weissbrich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Double Blind ◽

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

10.1016/j.jhep.2005.09.015 ◽

2006 ◽

Vol 44 (2) ◽

pp. 275-282 ◽

Cited By ~ 47

Author(s):

Peter Ferenci ◽

Elisabeth Formann ◽

Hermann Laferl ◽

Michael Gschwantler ◽

Franz Hackl ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Peginterferon Alfa

Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study

World Journal of Clinical Cases ◽

10.12998/wjcc.v9.i30.9059 ◽

2021 ◽

Vol 9 (30) ◽

pp. 9059-9069

Author(s):

Panot Sainamthip ◽

Chutcharn Kongphanich ◽

Naiyarat Prasongsook ◽

Sakkarin Chirapongsathorn

Keyword(s):

Single Dose ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Carcinoma Patient

JET-HCC: A phase 3 randomized, double-blind, placebo-controlled study of tivantinib as a second-line therapy in patients with c-Met high hepatocellular carcinoma

Annals of Oncology ◽

10.1093/annonc/mdx369.003 ◽

2017 ◽

Vol 28 ◽

pp. v210 ◽

Cited By ~ 9

Author(s):

S. Kobayashi ◽

K. Ueshima ◽

M. Moriguchi ◽

T. Takayama ◽

N. Izumi ◽

...

Keyword(s):

Controlled Study ◽

Second Line ◽

Second Line Therapy ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Line Therapy

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2008.03781.x ◽

2008 ◽

Vol 28 (5) ◽

pp. 574-580 ◽

Cited By ~ 54

Author(s):

J. F. ROSSIGNOL ◽

S. M. KABIL ◽

Y. EL-GOHARY ◽

A. ELFERT ◽

E. B. KEEFFE

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Double Blind ◽

Genotype 4 ◽

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide Plus Peginterferon and Ribavirin in Naïve Patients With Chronic Hepatitis C Genotype 1 Infection: Final Report

Gastroenterology ◽

10.1053/j.gastro.2010.05.067 ◽

2010 ◽

Vol 139 (1) ◽

pp. e18 ◽

Cited By ~ 4

Author(s):

Bruce R. Bacon ◽

Mitchell L. Shiffman ◽

Joseph K. Lim ◽

Arthur Berman ◽

Vinod K. Rustgi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Ii ◽

Controlled Study ◽

Final Report ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Peginterferon And Ribavirin

37 Treatment of advanced hepatocellular carcinoma (HCC) by seocalcitol (A vit D analogue): An international randomized double-blind placebo-controlled study in 747 patients

10.1016/s0168-8278(05)81449-7 ◽

2005 ◽

Vol 42 ◽

pp. 17 ◽

Cited By ~ 5

Keyword(s):

Controlled Study ◽

Advanced Hepatocellular Carcinoma ◽

Double Blind ◽